These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 31658138)

  • 1. CHA2DS2-Vasc score and saphenous vein graft disease in patients with coronary artery bypass graft surgery.
    Yarlioglues M; Oksuz F; Yalcinkaya D; Duran M; Murat SN
    Coron Artery Dis; 2020 May; 31(3):243-247. PubMed ID: 31658138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between lymphocyte-to-monocyte ratio and saphenous vein graft patency in patients with coronary artery bypass graft.
    Oksuz F; Elcik D; Yarlioglues M; Duran M; Ozturk S; Celik IE; Kurtul A; Kilic A; Murat SN
    Biomark Med; 2017 Oct; 11(10):867-876. PubMed ID: 28976779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red blood cell distribution width in saphenous vein graft disease.
    Akyel A; Celik IE; Oksüz F; Cay S; Karadeniz M; Kurtul A; Ocek AH; Murat SN
    Can J Cardiol; 2013 Apr; 29(4):448-51. PubMed ID: 22926040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A five-parameter score for predicting saphenous vein graft degenerative and/or occlusive disease in recurring ischemic symptoms after one year post coronary artery bypass grafting.
    Li XW; Cui Z; Xiao JY; Gao MD; Zhang M; Zhang WJ; Tian FS; Song Y; Liu YW; Yao ZH; Ma J; Liu Y; Gao J
    Perfusion; 2023 May; 38(4):843-852. PubMed ID: 35583035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative importance of patient, procedural and anatomic risk factors for early vein graft thrombosis after coronary artery bypass graft surgery.
    McLean RC; Nazarian SM; Gluckman TJ; Schulman SP; Thiemann DR; Shapiro EP; Conte JV; Thompson JB; Shafique I; McNicholas KW; Villines TC; Laws KM; Rade JJ
    J Cardiovasc Surg (Torino); 2011 Dec; 52(6):877-85. PubMed ID: 22051997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Platelet to Lymphocyte Ratio and Saphenous Vein Graft Disease.
    Yayla Ç; Canpolat U; Akyel A; Yayla KG; Yilmaz S; Açikgöz SK; Özcan F; Turak O; Doğan M; Yeter E; Aydoğdu S
    Angiology; 2016 Feb; 67(2):133-8. PubMed ID: 25818104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind, placebo-controlled trial investigating the effect of ticagrelor on saphenous vein graft patency in patients undergoing coronary artery bypass grafting surgery-Rationale and design of the POPular CABG trial.
    Willemsen LM; Janssen PWA; Hackeng CM; Kelder JC; Tijssen JGP; van Straten AHM; Soliman-Hamad MA; Deneer VHM; Daeter EJ; Sonker U; Klein P; Ten Berg JM
    Am Heart J; 2020 Feb; 220():237-245. PubMed ID: 31884246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of saphenous vein graft radiographic markers on clinical events and angiographic parameters.
    Olenchock SA; Karmpaliotis D; Gibson WJ; Murphy SA; Southard MC; Ciaglo L; Buros J; Mack MJ; Alexander JH; Harrington RA; Califf RM; Kouchoukos NT; Ferguson TB; Gibson CM
    Ann Thorac Surg; 2008 Feb; 85(2):520-4. PubMed ID: 18222256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between dual antiplatelet treatment (DAPT) score and saphenous venous grafts patency after coronary artery bypass grafting surgery.
    Bayam E; Öztürkeri B; Yıldırım E; Kalçık M; Küp A; Çakmak EÖ; Günay N; Güner A; Kalkan S; Karaduman A; Kahyaoğlu M; Zehir R
    Acta Cardiol; 2021 Sep; 76(7):785-791. PubMed ID: 33880976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between proprotein convertase subtilisin/kexin type 9 and late saphenous vein graft disease after coronary artery bypass grafting: a cross-sectional study.
    Gao J; Wang HB; Xiao JY; Ren M; Reilly KH; Li YM; Liu Y
    BMJ Open; 2018 Jul; 8(7):e021951. PubMed ID: 29991632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of graft vessel versus native vessel strategies for late saphenous vein graft disease after coronary artery bypass grafting].
    Li XW; Liu Y; Gao J; Gao MD; Xiao JY; Qu ZP; Wang YY; Feng LJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 May; 48(5):367-372. PubMed ID: 32450652
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationship between Serum Albumin Level and Monocyte-to-High-Density Lipoprotein Cholesterol Ratio with Saphenous Vein Graft Disease in Coronary Bypass.
    Akboga MK; Yayla C; Balci KG; Ozeke O; Maden O; Kisacik H; Temizhan A; Aydogdu S
    Thorac Cardiovasc Surg; 2017 Jun; 65(4):315-321. PubMed ID: 27111497
    [No Abstract]   [Full Text] [Related]  

  • 13. Relationship between plasma homocysteine levels and saphenous vein graft disease after coronary artery bypass grafts.
    Iwama Y; Mokuno H; Watanabe Y; Shimada K; Yokoi H; Daida H; Hosoda Y; Yamaguchi H
    Jpn Heart J; 2001 Sep; 42(5):553-62. PubMed ID: 11804297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary artery bypass graft failure after on-pump and off-pump coronary artery bypass: findings from PREVENT IV.
    Magee MJ; Alexander JH; Hafley G; Ferguson TB; Gibson CM; Harrington RA; Peterson ED; Califf RM; Kouchoukos NT; Herbert MA; Mack MJ;
    Ann Thorac Surg; 2008 Feb; 85(2):494-9; discussion 499-500. PubMed ID: 18222251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of the Logistic Clinical Syntax Score in Prediction of Saphenous Vein Graft Failure in Patients Undergoing Coronary Artery Bypass Grafting.
    Ozturk D; Celık O; Cakmak HA; Akın F; Aslan S; Enhos A; Tasbulak O; Ayca B; Erkanlı K; Bakır İ
    Angiology; 2015 Sep; 66(8):714-20. PubMed ID: 25385816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CHA
    Maden O; Çakmak Karaaslan Ö; Kanal Y; Yakut İ; Yaman NM; Könte HC; Balcı KG; Selçuk MT; Selçuk H
    Herz; 2022 Oct; 47(5):456-464. PubMed ID: 34608522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between elevated levels of serum uric acid and saphenous vein graft disease.
    Tavil Y; Sen N; Hizal F; Açikgöz SK; Taşoğlu I; Topal S; Yalçin MR
    Turk Kardiyol Dern Ars; 2008 Jan; 36(1):14-8. PubMed ID: 18453781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plaque composition by virtual histology intravascular ultrasound and clinical outcomes after percutaneous coronary intervention in saphenous vein graft disease patients: study protocol of a prospective cohort study.
    Liu Y; Wang HB; Li X; Xiao JY; Wang JX; Reilly KH; Sun B; Gao J
    BMC Cardiovasc Disord; 2018 Dec; 18(1):233. PubMed ID: 30541457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does CHA
    Kalyoncuoglu M; Ozturk S; Sahin M
    Braz J Cardiovasc Surg; 2019 Dec; 34(5):542-549. PubMed ID: 31112030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adropin: a new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting.
    Demircelik B; Cakmak M; Nazli Y; Gurel OM; Akkaya N; Cetin M; Cetin Z; Selcoki Y; Kurtul A; Eryonucu B
    Clin Invest Med; 2014 Oct; 37(5):E338-44. PubMed ID: 25282140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.